Przemyslaw Puz
Katowice, SL 40635, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Longitudinal Changes in Neutrophil-to-Lymphocyte and Monocyte-to-Lymphocyte Ratios During Multiple Sclerosis Relapse.
Journal: Journal of clinical medicine
Published: April 27, 2026
Twenty-Four-Month Real-World Outcomes of Ofatumumab in Relapsing-Remitting Multiple Sclerosis: A Multicenter Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: March 02, 2026
Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications.
Journal: Medicina (Kaunas, Lithuania)
Published: January 26, 2026
Selected Serum Biomarkers in Patients with Relapsing-Remitting Multiple Sclerosis-A 3-Year Prospective Pilot Study.
Journal: Medical sciences (Basel, Switzerland)
Published: October 18, 2025
Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients-A Multicenter Experience from Tertiary Referral Centers.
Journal: Medicina (Kaunas, Lithuania)
Published: August 06, 2025
The cryptogenic stroke patient's pathway and the qualification process for a patent foramen ovale closure: Experiences of the NeuroHeart Team.
Journal: Kardiologia polska
Published: July 09, 2025
Did COVID-19 Pandemic Change the Course of Multiple Sclerosis? A Retrospective Eight-Year Study.
Journal: Health science reports
Published: May 18, 2025
Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study.
Journal: Frontiers in neurology
Published: May 10, 2025
The Usefulness of Outpatient Cardiac Telemetry in Patients with Cryptogenic Stroke.
Journal: Journal of clinical medicine
Published: April 22, 2024
Direct Exposure to Outdoor Air Pollution Worsens the Functional Status of Stroke Patients Treated with Mechanical Thrombectomy.
Journal: Journal of clinical medicine
Published: December 20, 2023
Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland.
Journal: Neurologia i neurochirurgia polska
Published: July 08, 2023
Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic.
Journal: Neurologia i neurochirurgia polska
Published: March 01, 2023
Last Updated: 09/26/2026